Xencor, Inc. · NASDAQ:XNCR
BVF PARTNERS L P/IL reported a 9.99% stake in Xencor, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
BVF PARTNERS L P/IL reported a 9.99% stake in Xencor, Inc., 7,133,720 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 7,133,720
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.30% | 3,798,627 |
| BVF I GP LLC | 5.30% | 3,798,627 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.90% | 2,787,735 |
| BVF II GP LLC | 3.90% | 2,787,735 |
| Biotechnology Value Trading Fund OS LP | 0.60% | 439,372 |
| BVF Partners OS Ltd. | 0.60% | 439,372 |
| BVF GP HOLDINGS LLC | 9.20% | 6,586,362 |
| BVF PARTNERS L P/IL | 9.99% | 7,133,720 |
| BVF INC/IL | 9.99% | 7,133,720 |
| LAMPERT MARK N | 9.99% | 7,133,720 |
Source
Related
- Xencor, Inc.
- Bvf Partners L P
- Xencor, Inc. shareholders
- Schedule 13G · Bvf Partners L P · Oct 17, 2025
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Feigal Ellen · Jul 8, 2026
- Form 4 · Gorman Kevin Charles · Jul 8, 2026
- Form 4 · Gustafson Kurt A · Jul 8, 2026
- Form 4 · Klencke Barbara · Jul 8, 2026